Allergan categorically rejects Valeant's $53B takeover offer
Tuesday, June 10, 2014 - 11:29
in Mathematics & Economics
Ananth BaligaIRVINE, Calif., June 10 (UPI) -- Allergan's board announced Tuesday that it had rejected a $53 billion takeover bid by Valeant Pharmaceuticals saying the offer wasn't worth considering.